Skip to content

ICU Medical ICUI Asia Pacific — Revenue

Similar metrics at other companies

Itron logo
ITRIAsia Pacific — Revenue
$31.26M+27.0%
V.F. Corporation logo
VFCAsia-Pacific — Revenue
$336.43M+0.1%
Oceaneering International logo
OIIAsia Pacific — Revenue
$59.65M+11.4%
Cabot Corporation logo
CBTAsia Pacific — Revenue
$341M+1.2%
JBT Marel Corporation logo
JBTMAsia Pacific — Revenue
$68M-11.7%
FactSet Research Systems logo
FDSAsia Pacific — Revenue
$62.22M+8.0%

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.51B-6.3%
Enterprise value$4.58B-10.6%
P/E75.3×+70.9×
P/S1.6×+0.1×

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's asia pacific — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's asia pacific — revenue?
ICU Medical (ICUI) reported asia pacific — revenue of $58.3M in Q1 2026.
How has ICU Medical's asia pacific — revenue changed year-over-year?
ICU Medical's asia pacific — revenue decreased by 1.9% year-over-year, from $59.41M to $58.3M.
What does asia pacific — revenue mean?
This metric represents the total net sales generated from products and services sold within the Asia Pacific geographic region. It serves as a key indicator of the company's market penetration, demand, and growth trajectory in this specific international territory. Monitoring this figure helps investors assess the effectiveness of regional sales strategies and the impact of local healthcare market dynamics on overall corporate performance.